07:00 , May 7, 2015 |  BC Innovations  |  Distillery Techniques

Techniques: Mutations in potassium channel Kv10.1 (KCNH1) and vacuolar H+ ATPase B2 (ATP6V1B2) as diagnostic markers of Zimmermann-Laband syndrome (ZLS)

Biomarkers KCNH1 ATP6V1B2 potassium channel Kv10.1 (KCNH1) University Medical Center Hamburg-Eppendorf...
07:00 , Aug 6, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Musculoskeletal disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Osteoporosis ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 (ATP6V1B2) In vitro studies suggest that inhibiting interactions between ATP6V1B2 and microfilaments could help treat...